Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index
Background: Our objective was to develop a prognostic stratification tool that enables patients with cancer and pulmonary embolism (PE), whether incidental or symptomatic, to be classified according to the risk of serious complications within 15 days. Methods: The sample comprised cases from a natio...
| Authors: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Status: | Published version |
| Publication Date: | 2017 |
| Country: | España |
| Institution: | Universidad de Barcelona |
| Repository: | Dipòsit Digital de la UB |
| OAI Identifier: | oai:diposit.ub.edu:2445/124406 |
| Online Access: | https://hdl.handle.net/2445/124406 |
| Access Level: | Open access |
| Keyword: | Embòlia pulmonar Càncer Pulmonary embolism Cancer |
| id |
ES_a794338640674650dca4cb5c1b5f5f4e |
|---|---|
| oai_identifier_str |
oai:diposit.ub.edu:2445/124406 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY IndexCarmona Bayonas, AlbertoJiménez Fonseca, PaulaFont, C.Fenoy, F.Otero, RemediosBeato, CarmenPlasencia, J. M.Biosca, M.Sánchez, M.Benegas, MarianaCalvo Temprano, D.Varona, D.Faez, L.Haba, I. de laAntonio, MaiteMadridano, O.Solis, M. P.Ramchandani, AvinashCastanon, E.Marchena, Pablo JavierMartin, M.Ayala de la Peña, FranciscoVicente, VicenteEmbòlia pulmonarCàncerPulmonary embolismCancerBackground: Our objective was to develop a prognostic stratification tool that enables patients with cancer and pulmonary embolism (PE), whether incidental or symptomatic, to be classified according to the risk of serious complications within 15 days. Methods: The sample comprised cases from a national registry of pulmonary thromboembolism in patients with cancer (1075 patients from 14 Spanish centres). Diagnosis was incidental in 53.5% of the events in this registry. The Exhaustive CHAID analysis was applied with 10-fold crossvalidation to predict development of serious complications following PE diagnosis. Results: About 208 patients (19.3%, 95% confidence interval (CI), 17.1-21.8%) developed a serious complication after PE diagnosis. The 15-day mortality rate was 10.1%, (95% CI, 8.4-12.1%). The decision tree detected six explanatory covariates: Hestia-like clinical decision rule (any risk criterion present vs none), Eastern Cooperative Group performance scale (ECOG-PS; <2 vs >= 2), O-2 saturation (<90 vs >= 90%), presence of PE-specific symptoms, tumour response (progression, unknown, or not evaluated vs others), and primary tumour resection. Three risk classes were created (low, intermediate, and high risk). The risk of serious complications within 15 days increases according to the group: 1.6, 9.4, 30.6%; P<0.0001. Fifteen-day mortality rates also rise progressively in low-, intermediate-, and high-risk patients: 0.3, 6.1, and 17.1%; P<0.0001. The cross-validated risk estimate is 0.191 (s.e. = 0.012). The optimism-corrected area under the receiver operating characteristic curve is 0.779 (95% CI, 0.717-0.840). Conclusions: We have developed and internally validated a prognostic index to predict serious complications with the potential to impact decision-making in patients with cancer and PE.Nature Publishing2017info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://hdl.handle.net/2445/124406Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésReproducció del document publicat a: https://doi.org/10.1038/bjc.2017.48British Journal of Cancer, 2017, vol. 116, num. 8, p. 994-1001https://doi.org/10.1038/bjc.2017.48cc by-nc-sa (c) Carmona Bayonas et al., 2017http://creativecommons.org/licenses/by-nc-sa/3.0/es/info:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/1244062026-05-27T06:46:51Z |
| dc.title.none.fl_str_mv |
Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index |
| title |
Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index |
| spellingShingle |
Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index Carmona Bayonas, Alberto Embòlia pulmonar Càncer Pulmonary embolism Cancer |
| title_short |
Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index |
| title_full |
Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index |
| title_fullStr |
Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index |
| title_full_unstemmed |
Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index |
| title_sort |
Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index |
| dc.creator.none.fl_str_mv |
Carmona Bayonas, Alberto Jiménez Fonseca, Paula Font, C. Fenoy, F. Otero, Remedios Beato, Carmen Plasencia, J. M. Biosca, M. Sánchez, M. Benegas, Mariana Calvo Temprano, D. Varona, D. Faez, L. Haba, I. de la Antonio, Maite Madridano, O. Solis, M. P. Ramchandani, Avinash Castanon, E. Marchena, Pablo Javier Martin, M. Ayala de la Peña, Francisco Vicente, Vicente |
| author |
Carmona Bayonas, Alberto |
| author_facet |
Carmona Bayonas, Alberto Jiménez Fonseca, Paula Font, C. Fenoy, F. Otero, Remedios Beato, Carmen Plasencia, J. M. Biosca, M. Sánchez, M. Benegas, Mariana Calvo Temprano, D. Varona, D. Faez, L. Haba, I. de la Antonio, Maite Madridano, O. Solis, M. P. Ramchandani, Avinash Castanon, E. Marchena, Pablo Javier Martin, M. Ayala de la Peña, Francisco Vicente, Vicente |
| author_role |
author |
| author2 |
Jiménez Fonseca, Paula Font, C. Fenoy, F. Otero, Remedios Beato, Carmen Plasencia, J. M. Biosca, M. Sánchez, M. Benegas, Mariana Calvo Temprano, D. Varona, D. Faez, L. Haba, I. de la Antonio, Maite Madridano, O. Solis, M. P. Ramchandani, Avinash Castanon, E. Marchena, Pablo Javier Martin, M. Ayala de la Peña, Francisco Vicente, Vicente |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
Embòlia pulmonar Càncer Pulmonary embolism Cancer |
| topic |
Embòlia pulmonar Càncer Pulmonary embolism Cancer |
| description |
Background: Our objective was to develop a prognostic stratification tool that enables patients with cancer and pulmonary embolism (PE), whether incidental or symptomatic, to be classified according to the risk of serious complications within 15 days. Methods: The sample comprised cases from a national registry of pulmonary thromboembolism in patients with cancer (1075 patients from 14 Spanish centres). Diagnosis was incidental in 53.5% of the events in this registry. The Exhaustive CHAID analysis was applied with 10-fold crossvalidation to predict development of serious complications following PE diagnosis. Results: About 208 patients (19.3%, 95% confidence interval (CI), 17.1-21.8%) developed a serious complication after PE diagnosis. The 15-day mortality rate was 10.1%, (95% CI, 8.4-12.1%). The decision tree detected six explanatory covariates: Hestia-like clinical decision rule (any risk criterion present vs none), Eastern Cooperative Group performance scale (ECOG-PS; <2 vs >= 2), O-2 saturation (<90 vs >= 90%), presence of PE-specific symptoms, tumour response (progression, unknown, or not evaluated vs others), and primary tumour resection. Three risk classes were created (low, intermediate, and high risk). The risk of serious complications within 15 days increases according to the group: 1.6, 9.4, 30.6%; P<0.0001. Fifteen-day mortality rates also rise progressively in low-, intermediate-, and high-risk patients: 0.3, 6.1, and 17.1%; P<0.0001. The cross-validated risk estimate is 0.191 (s.e. = 0.012). The optimism-corrected area under the receiver operating characteristic curve is 0.779 (95% CI, 0.717-0.840). Conclusions: We have developed and internally validated a prognostic index to predict serious complications with the potential to impact decision-making in patients with cancer and PE. |
| publishDate |
2017 |
| dc.date.none.fl_str_mv |
2017 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/2445/124406 |
| url |
https://hdl.handle.net/2445/124406 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
Reproducció del document publicat a: https://doi.org/10.1038/bjc.2017.48 British Journal of Cancer, 2017, vol. 116, num. 8, p. 994-1001 https://doi.org/10.1038/bjc.2017.48 |
| dc.rights.none.fl_str_mv |
cc by-nc-sa (c) Carmona Bayonas et al., 2017 http://creativecommons.org/licenses/by-nc-sa/3.0/es/ info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
cc by-nc-sa (c) Carmona Bayonas et al., 2017 http://creativecommons.org/licenses/by-nc-sa/3.0/es/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Nature Publishing |
| publisher.none.fl_str_mv |
Nature Publishing |
| dc.source.none.fl_str_mv |
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) reponame:Dipòsit Digital de la UB instname:Universidad de Barcelona |
| instname_str |
Universidad de Barcelona |
| reponame_str |
Dipòsit Digital de la UB |
| collection |
Dipòsit Digital de la UB |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869415789865467904 |
| score |
15,300719 |